home
顺序
主题
题目
日子
66
Immunomic Therapeutics to Present at AACR Virtual Annual Meeting II
admin
2020.06.12
65
Elevar to accept Dr. Gelder for global clinical and marketing
admin
2020.05.26
64
HLB Chairman Jin Yang-gon reveals his ambition to take a global pharma
admin
2020.05.19
63
HLB Rivoceranib’s Clinical Results were 'Excellent' in Cervical Cancer, NSCLC, and Soft Tissue Sarcoma
admin
2020.05.14
62
HLB announces 16 clinical results of Rivoceranib at ASCO
admin
2020.05.14
61
Report from Hanyang Securities on HLB
admin
 
60
Elevar Therapeutics acquires Global Rights to European approved Apealea® from Oasmia Pharmaceutical
admin
 
59
JAMA announces Rivoceranib's NSCLC combination therapy
admin
2020.04.27
58
Immunomic Therapeutics to initiate developing COVID-19 Vaccine
admin
 
57
Rivoceranib approved for phase 3 clinical trial as first-line lung cancer treatment
admin